Free Trial

HealthEquity, Inc. (NASDAQ:HQY) Given Average Rating of "Buy" by Brokerages

HealthEquity logo with Medical background

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have earned a consensus rating of "Buy" from the eleven research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, nine have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $118.09.

Several research firms have recently issued reports on HQY. Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. KeyCorp dropped their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Royal Bank Of Canada increased their price objective on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. Barrington Research increased their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research report on Thursday, June 5th. Finally, Bank of America increased their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th.

Get Our Latest Report on HQY

HealthEquity Stock Performance

Shares of HQY stock opened at $104.88 on Friday. HealthEquity has a one year low of $65.01 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06. The company has a 50 day moving average price of $98.01 and a 200 day moving average price of $98.00. The firm has a market capitalization of $9.07 billion, a price-to-earnings ratio of 76.55, a price-to-earnings-growth ratio of 1.61 and a beta of 0.49.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The firm had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. During the same quarter in the prior year, the business posted $0.80 earnings per share. Sell-side analysts anticipate that HealthEquity will post 2.32 EPS for the current year.

Insider Activity

In other HealthEquity news, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 304,581 shares of company stock worth $33,664,018. 1.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Versant Capital Management Inc acquired a new stake in shares of HealthEquity during the first quarter worth $28,000. WPG Advisers LLC acquired a new stake in shares of HealthEquity during the first quarter worth $28,000. Transce3nd LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth $29,000. Smartleaf Asset Management LLC raised its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares during the period. Finally, Proficio Capital Partners LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth $39,000. 99.55% of the stock is currently owned by institutional investors.

About HealthEquity

(Get Free Report

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines